Zero Candida announced officially been granted Patent No. 12654025B2 -- a meaningful milestone that reflects our commitment to innovation, technology, and long-term impact
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device
Zero Candida Technologies Reports Financial Results for Three and Six Months Ended June 30, 2025 and Provides Business Update
emerging tech investing Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030
medical device investing Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025
medical device investing Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)
Freegold Drills 2.08 g/t Au over 62.1 m within 102.3 m of 1.67 g/t Au in Infill Drilling at Golden Summit
One Bullion Commences High-Resolution Airborne Geophysical Survey at Vumba Gold Project in Botswana and Appoints Joe Van Wyk as Vice President, Exploration
Metalsource Mining Expands Silver Hill District Through Strategic Land Acquisition as Exploration Footprint Continues to Grow
Generation Uranium Starts Summer 2026 Field Program at the Yath Project, Kivalliq Region, Nunavut. Project,
